Display options
Cite
Bonn-Miller MO, Heinz AJ, Smith EV, et al. Preliminary Development of a Brief Cannabis Use Disorder Screening Tool: The Cannabis Use Disorder Identification Test Short-Form. Cannabis Cannabinoid Res. 2016;1(1):252-261doi: 10.1089/can.2016.0022.
Bonn-Miller, M. O., Heinz, A. J., Smith, E. V., Bruno, R., & Adamson, S. (2016). Preliminary Development of a Brief Cannabis Use Disorder Screening Tool: The Cannabis Use Disorder Identification Test Short-Form. Cannabis and cannabinoid research, 1(1), 252-261. https://doi.org/10.1089/can.2016.0022
Bonn-Miller, Marcel O, et al. "Preliminary Development of a Brief Cannabis Use Disorder Screening Tool: The Cannabis Use Disorder Identification Test Short-Form." Cannabis and cannabinoid research vol. 1,1 (2016): 252-261. doi: https://doi.org/10.1089/can.2016.0022
Bonn-Miller MO, Heinz AJ, Smith EV, Bruno R, Adamson S. Preliminary Development of a Brief Cannabis Use Disorder Screening Tool: The Cannabis Use Disorder Identification Test Short-Form. Cannabis Cannabinoid Res. 2016 Dec 01;1(1):252-261. doi: 10.1089/can.2016.0022. eCollection 2016. PMID: 28861497; PMCID: PMC5531365.
Copy Download .nbib Format: NLM
Share it on

Cannabis Cannabinoid Res. 2016 Dec 01;1(1):252-261. doi: 10.1089/can.2016.0022. eCollection 2016.

Preliminary Development of a Brief Cannabis Use Disorder Screening Tool: The Cannabis Use Disorder Identification Test Short-Form.

Cannabis and cannabinoid research

Marcel O Bonn-Miller, Adrienne J Heinz, Everett V Smith, Raimondo Bruno, Simon Adamson

Affiliations

  1. Center for Innovation to Implementation, VA Palo Alto Health Care System, Menlo Park, California.
  2. National Center for PTSD, VA Palo Alto Health Care System, Menlo Park, California.
  3. Center of Excellence in Substance Abuse Treatment and Education, Philadelphia VA Medical Center, Philadelphia, Pennsylvania.
  4. Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
  5. Department of Educational Psychology, University of Illinois at Chicago, Chicago, Illinois.
  6. School of Medicine (Psychology), University of Tasmania, Hobart, Australia.
  7. Department of Psychological Medicine, University of Otago, Christchurch, New Zealand.

PMID: 28861497 PMCID: PMC5531365 DOI: 10.1089/can.2016.0022

[No abstract available.]

Keywords: assessment; cannabis; cannabis use disorder; screening

Conflict of interest statement

No competing financial interests exist.

References

  1. Arch Intern Med. 1998 Sep 14;158(16):1789-95 - PubMed
  2. J Gen Intern Med. 2011 Mar;26(3):299-306 - PubMed
  3. Arch Clin Neuropsychol. 1999 Aug;14(6):481-7 - PubMed
  4. Subst Abuse Treat Prev Policy. 2012 Jul 24;7:31 - PubMed
  5. Drug Alcohol Depend. 1996 Jul;41(3):179-87 - PubMed
  6. Drug Alcohol Depend. 2009 Mar 1;100(3):221-7 - PubMed
  7. JAMA. 2004 May 5;291(17):2114-21 - PubMed
  8. Addiction. 1993 Jun;88(6):791-804 - PubMed
  9. Am J Psychiatry. 2004 Nov;161(11):1967-77 - PubMed
  10. Psychol Addict Behav. 2016 Feb;30(1):73-81 - PubMed
  11. Drug Alcohol Rev. 2003 Sep;22(3):309-15 - PubMed
  12. Mil Med. 2012 Jul;177(7):786-8 - PubMed
  13. Psychol Serv. 2012 Nov;9(4):404-16 - PubMed
  14. Am J Manag Care. 2006 Oct;12(10):597-606 - PubMed
  15. Subst Abus. 2007;28(3):7-30 - PubMed
  16. Drug Alcohol Depend. 1995 Jul;39(1):37-44 - PubMed
  17. Psychol Addict Behav. 2012 Dec;26(4):801-11 - PubMed
  18. N Engl J Med. 2014 Jun 5;370(23):2219-27 - PubMed
  19. Drug Alcohol Depend. 2010 Jul 1;110(1-2):137-43 - PubMed
  20. J Stud Alcohol Drugs. 2013 Jul;74(4):614-21 - PubMed
  21. Int J Methods Psychiatr Res. 2010 Sep;19(3):142-55 - PubMed
  22. J Clin Exp Neuropsychol. 2004 Oct;26(7):891-902 - PubMed

Publication Types